4-(4-SUBSTITUTED PIPERAZINYL1YL)-BUTYLCARBOXAMIDES AS D3 DOPAMINE SUBTYPE SELECTIVE LIGANDS

Details for Australian Patent Application No. 2002329502 (hide)

Owner RICHTER GEDEON VEGYESZETI GYAR RT.

Inventors DOMANY, Gyorgy; KISS, Bela; GYERTYAN, Istvan; LASZLOVSZKY, Istvan; HORVATH, Attila; NOGRADI, Katalin; GALAMBOS, Janos; ACS, Tibor; BORZA, Istvan; BIELIK, Attila

Pub. Number AU-A-2002329502

PCT Number PCT/HU02/00095

PCT Pub. Number WO2003/028728

Priority P01 03987 28.09.01 HU

Filing date 25 September 2002

Wipo publication date 14 April 2003

International Classifications

A61K 031/496 - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

C07D 513/04 Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or

C07D 471/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 487/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

C07D 207/34 Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 239/26 Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 233/90 Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D 209/42 Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 031/495 - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 031/542 - ortho- or peri-condensed with heterocyclic ring systems

A61K 031/519 - ortho- or peri-condensed with heterocyclic rings

A61K 031/506 - not condensed and containing further heterocyclic rings

C07D 215/54 Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 295/12 Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 213/56 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

Event Publications

30 January 2003 Complete Application Filed

  Priority application(s): P01 03987 28.09.01 HU

26 June 2003 Application Open to Public Inspection

  Published as AU-A-2002329502

17 June 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002329503-PHARMACEUTICAL COMPOSITION COMPRISING METFORMIN AND N- `2-HYDROXY-3-(1-PIPERIDINYL)-PRO POXY! PYRIDINE1-OXIDE-3-CARBOXIMIDOYL CHLORIDE

2002329501-4-(1-PIPERIDINY)-BUTYLCARBOXAMI DE AS D3 DOPAMINE RECEPTOR SUBTYPE SELECTIVE LIGANDS